Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Recruiting 3Completed 3Unknown 1Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 2Lymphoid 1

Conditions

Breast Neoplasms 2Lymphoma, Follicular 1

Interventions

Cyclophosphamide 1492Cisplatin 1413Paclitaxel 1316Radiotherapy 1261Carboplatin 1249Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700Etoposide 678pembrolizumab 677Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Loratadine × Clear all
NCT06265077 2024-12-13

Novel Preventive Approach Against Filgrastim-Induced Bone Pain in Cancer Patients

Mansoura University

Phase 1/2 Completed
58 enrolled
Breast

Breast Neoplasms

NCT01712009 2018-01-30

NOLAN

Amgen

Phase 2 Completed
600 enrolled 15 charts
Breast

Breast Neoplasms

NCT02007434 2015-07-28

Patient Experience Study of Deoxycholic Acid Injection

Kythera Biopharmaceuticals

Phase 3 Completed
84 enrolled 24 charts
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡